Motion Sickness News and Research

RSS
Motion sickness, also termed kinetosis, is a generalized term that is used to describe an unpleasant set of symptoms like nausea, vomiting and dizziness that occurs when a person is travelling.
First interactive 3D video hologram displays live footage of internal organs

First interactive 3D video hologram displays live footage of internal organs

Researchers develop new method to combat VR sickness

Researchers develop new method to combat VR sickness

Researchers explore key factors to improve astronauts’ nutrition needs during space missions

Researchers explore key factors to improve astronauts’ nutrition needs during space missions

Combination of exercise and artificial gravity may reduce effects of extended weightlessness in space

Combination of exercise and artificial gravity may reduce effects of extended weightlessness in space

New study suggests that bright light after night shift may have potential to improve driving performance

New study suggests that bright light after night shift may have potential to improve driving performance

Acacia Pharma begins APD421 Phase 3 study in combination with standard anti-emetics for PONV

Acacia Pharma begins APD421 Phase 3 study in combination with standard anti-emetics for PONV

23andMe announces publication of genome-wide association study of motion sickness

23andMe announces publication of genome-wide association study of motion sickness

Commercial space transportation industrys need to define medical care standards

Commercial space transportation industrys need to define medical care standards

Columbia University professor recommends vaccination for people travelling abroad

Columbia University professor recommends vaccination for people travelling abroad

Acacia Pharma reports positive results from APD421 Phase 3 studies for management of PONV

Acacia Pharma reports positive results from APD421 Phase 3 studies for management of PONV

Prestige Brands’ net revenues decrease $144.3M to 6.6% in Q4 and FY 2014

Prestige Brands’ net revenues decrease $144.3M to 6.6% in Q4 and FY 2014

Prestige Brands Holdings signs agreement to acquire Insight Pharmaceuticals for $750 million

Prestige Brands Holdings signs agreement to acquire Insight Pharmaceuticals for $750 million

Prestige Brands Holdings signs agreement for acquisition of Hydralyte

Prestige Brands Holdings signs agreement for acquisition of Hydralyte

Proactive health measures are the secret to health and happiness

Proactive health measures are the secret to health and happiness

Meclizine drug has the potential to treat certain infectious diseases and cancer

Meclizine drug has the potential to treat certain infectious diseases and cancer

Scientists identify key neurons that sense unexpected motion and have implications for motion sickness

Scientists identify key neurons that sense unexpected motion and have implications for motion sickness

Stimulation of P6 antiemetic point with acupressure wristbands reduces migraine nausea

Stimulation of P6 antiemetic point with acupressure wristbands reduces migraine nausea

Prestige Brands Holdings reports record revenues of $154.5 million in fourth quarter 2013

Prestige Brands Holdings reports record revenues of $154.5 million in fourth quarter 2013

Diagnostic hallmarks of POTS identified

Diagnostic hallmarks of POTS identified

BD receives FDA approval for second prefilled injectable drug

BD receives FDA approval for second prefilled injectable drug